Tilray Inc (NASDAQ:TLRY – Get Free Report) shares rose 2.7% during mid-day trading on Wednesday . The stock traded as high as $1.92 and last traded at $1.91. Approximately 6,516,910 shares changed hands during trading, a decline of 75% from the average daily volume of 25,715,840 shares. The stock had previously closed at $1.87.
Tilray Stock Up 3.0 %
The company has a debt-to-equity ratio of 0.10, a current ratio of 2.27 and a quick ratio of 1.42. The firm has a 50-day moving average of $1.79 and a 200 day moving average of $1.88. The stock has a market capitalization of $1.62 billion, a price-to-earnings ratio of -4.42 and a beta of 2.19.
Tilray (NASDAQ:TLRY – Get Free Report) last released its quarterly earnings data on Monday, July 29th. The company reported ($0.04) EPS for the quarter, missing the consensus estimate of ($0.02) by ($0.02). Tilray had a negative net margin of 30.26% and a negative return on equity of 2.63%. The company had revenue of $229.90 million during the quarter, compared to analyst estimates of $226.20 million. During the same period in the previous year, the company posted ($0.15) EPS. The company’s quarterly revenue was up 24.8% compared to the same quarter last year. As a group, sell-side analysts forecast that Tilray Inc will post -0.12 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
About Tilray
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.
Featured Articles
- Five stocks we like better than Tilray
- How to Choose Top Rated Stocks
- Brinker International’s Price Dip is an Appetizing Entry Point
- How to buy stock: A step-by-step guide for beginners
- 3 Stocks That Could Beat the September Blues
- The Risks of Owning Bonds
- Canopy Growth Stock: Can It Sustain Recent Gains?
Receive News & Ratings for Tilray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray and related companies with MarketBeat.com's FREE daily email newsletter.